Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Introduction: Immune checkpoint inhibitors (ICIs) have transformed cancer treatment and are now the standard therapy for several gastrointestinal (GI) malignancies. Although they can improve survival, ICIs are associated with immune-related adverse events (irAEs) that may affect multiple organ systems, potentially impa...